Offering automated conversion of computed tomography angiography (CTA) into 3D images, Viz 3D CTA reportedly facilitates real-time insights into complex neurovascular anatomy.
While traditional neurovascular imaging poses challenges with manual 3D renderings, limited spatial context and difficulty in visualizing more distal vessel abnormalities, the launch of the artificial intelligence (AI) software Viz 3D CTA may provide a viable alternative.
Providing automated conversion of computed tomography angiography (CTA) scans into high-resolution 3D views in minutes, the Viz 3D CTA software enhances diagnostic clarity and efficiency, according to Viz.ai, the developer of the software.
The newly launched Viz 3D CTA software provides automated conversion of computed tomography angiography (CTA) scans into real-time, high-resolution 3D views of neurovascular anatomy, according to Viz.ai, the developer of the software. (Image courtesy of Viz.ai .)
The company said key attributes of Viz 3D CTA include skull-stripped views, automated post-processing and interactive tools including sagittal and axial rotation.
“Viz 3D CTA gives me a clearer, faster view of what’s going on. Being able to rotate the image and see vessels from different angles makes a big difference, especially in tricky areas,” said Benjamin Alwood, M.D., an assistant professor of vascular neurology at the University of Florida. “It’s also a great safety net for spotting occlusions that might otherwise be missed. Having this kind of clarity right away helps me make quicker, more confident decisions.”
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
July 22nd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.